PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
Adrenocortical carcinomas (ACCs) are heterogeneous cancers associated with a very poor prognosis. The improvement of prognostic tools and systemic therapy are urgently needed. Targeting the immune system using checkpoint inhibitors such as PD1/PDL1 inhibitors is an attractive novel therapeutic strat...
Shranjeno v:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2019-11-01
|
| Serija: | OncoImmunology |
| Teme: | |
| Online dostop: | http://dx.doi.org/10.1080/2162402X.2019.1655362 |
| Oznake: |
Brez oznak, prvi označite!
|